Riskpilot← Back to searchSign inGet full accessFotvård Hermelinen AB
ABActiveOrg 5592817612Sandviksgatan 60Physiotherapy activities · NACE 8695Est. 20201 employees
Revenue 2024
SEK 544K
-10% vs 2023
EBITDA margin
7.9%
+242% vs 2023
Equity ratio
108.9%
Financial strength
Net profit 2024
SEK 34K
+23586% vs 2023
| Revenue | SEK 544K | -10% |
| EBITDA | SEK 43K | +242% |
| Net profit | SEK 34K | +23586% |
| Total assets | SEK 111K | +5% |
| Equity | SEK 121K | +39% |
| Employees | 1 | — |
Legal name
Fotvård Hermelinen AB
Org number
5592817612
Legal form
Aktiebolag
NACE code
8695 · Physiotherapy activities
Founded
9 november 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Fotvård Hermelinen Vi välkomnar dig till fotvårdsbehandling där vi förutom sedvanlig medicinsk fotvård med fotbad, nagelklipp, filning av fötter, och avslutande fotmassage även behandlar: Liktornar Nagel- och fotsvamp Missfärgade naglar Nageltrång Hälsprickor Förhårdnader Förtjockade naglar Psoriasis naglar
Address
Sandviksgatan 60
Email
susanne.r.backstrom@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 646 | 681 | 607 | 544 |
| Staff expenses | — | −464 | −421 | −271 |
| EBITDA | 201 | 42 | −30 | 43 |
| Depreciation & amort. | −0 | — | — | — |
| EBIT | 201 | 42 | −30 | 43 |
| Net financials | −1 | −0 | −1 | 0 |
| Profit before tax | 150 | 42 | 1 | 43 |
| Tax | −32 | −9 | −1 | −9 |
| Net profit | 118 | 33 | 0 | 34 |
| Item | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total assets | 309 | 241 | 106 | 111 |
| Equity | 143 | 127 | 87 | 121 |
| Long-term debt | 0 | — | — | — |
| Short-term debt | 116 | 64 | 0 | −29 |
| Total debt | 116 | 64 | 0 | −29 |
EBITDA margin
7.9%
This company
15.8%
Market median
-50% vs market
20212024
Equity ratio
108.9%
This company
38.2%
Market median
+185% vs market
20212024
Return on equity
27.9%
This company
18.4%
Market median
+52% vs market
20212024
Net profit margin
6.2%
This company
8.1%
Market median
-23% vs market
20212024
Asset turnover
4.91×
This company
1.12×
Market median
+338% vs market
20212024
Debt / equity
-0.08×
This company
0.62×
Market median
+113% vs market
20212024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-11-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Fotvård Hermelinen AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jimmy Olavi Väyrynen | Deputy Board Member | 0 companies |
| Ritta Susanne Bäckström | Chairman | 0 companies |
| Stig Jan-Crister Riggo | Board of Directors | 0 companies |